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The inducible expression of antimicrobial peptide genes in Drosophila melanogaster is regulated by the
conserved Toll and peptidoglycan recognition protein LC/immune deficiency (PGRP-LC/IMD) signaling path-
ways. It has been proposed that the two pathways have independent functions and mediate the specificity of
innate immune responses towards different microorganisms. Scattered evidence also suggests that some
antimicrobial target genes can be activated by both Toll and IMD, albeit to different extents. This dual
activation can be mediated by independent stimulation or by cross-regulation of the two pathways. We show in
this report that the Toll and IMD pathways can interact synergistically, demonstrating that cross-regulation
occurs. The presence of Spa¨tzle (the Toll ligand) and gram-negative peptidoglycan (the PGRP-LC ligand)
together caused synergistic activation of representative target genes of the two pathways, including Drosomycin,
Diptericin, and AttacinA. Constitutive activation of Toll and PGRP-LC/IMD could mimic the synergistic
stimulation. RNA interference assays and promoter analyses demonstrate that cooperation of different NF-
B-related transcription factors mediates the synergy. These results illustrate how specific ligand binding by
separate upstream pattern recognition receptors can be translated into a broad-spectrum host response, a
hallmark of innate immunity.
Upon infection, insects mount a rapid antimicrobial re-
sponse that consists of many components, including antimicro-
bial peptides, hemocytes, and phenoloxidase-based melaniza-
tion (3, 19, 23, 38, 49). This insect antimicrobial response is
equivalent to the innate immune response in mammals (14).
Even though insects do not possess B and T lymphocytes, the
insect innate immune system can recognize different classes of
microorganisms and respond accordingly (25, 26).
A critical aspect of the Drosophila melanogaster innate im-
mune response is the inducible expression of a spectrum of
antimicrobial peptides which function synergistically to fight
microbial infections (3, 19, 23, 38, 49). The inducible expres-
sion of antimicrobial peptide genes is regulated by the Toll
and immune deficiency (IMD) pathways. In the absence of
these two pathways, the antimicrobial peptide genes cannot
be induced and the flies become more susceptible to many
microbes, even those that are normally nonpathogenic (12,
51, 53).
The IMD pathway regulates the response to gram-negative
bacterial infection. Gram-negative bacterium-derived diamino-
pimelic acid (DAP)-type peptidoglycan is recognized by up-
stream receptors called peptidoglycan recognition proteins LC
(PGRP-LC) and LE (4, 6, 12, 21, 26, 29, 44, 47, 48). The
recognition leads to activation of the adaptor protein IMD, a
homologue of the mammalian tumor necrosis factor receptor-
interacting protein RIP (5, 10). Other downstream compo-
nents of the IMD pathway include the Drosophila homologues
of the kinases TAK1, IKK, and JNK (12, 30, 35, 42, 43, 52).
These regulatory proteins converge onto the NF-B-related
transcription factor Relish. The signal-induced proteolytic
cleavage of Relish allows nuclear translocation of the active
N-terminal portion, which interacts with other proteins to
modulate the expression of antimicrobial peptide genes such as
Diptericin and AttacinA (15, 22, 45).
The Toll pathway regulates the response to gram-positive
bacterial and fungal infections. Gram-positive bacterium-de-
rived Lys-type peptidoglycan is recognized by upstream recep-
tors PGRP-SA and -SD, as well as gram-negative binding pro-
tein 1 (GNBP-1) (2, 9, 11, 33, 37). The fungal component that
stimulates the Toll pathway is not well defined. Nonetheless,
both infections cause activation of protease cascades and ulti-
mately cleavage of the host protein Spa¨tzle (20, 27, 28).
Cleaved Spa¨tzle serves as the ligand for Toll and induces the
expression of a subset of antimicrobial peptide genes, such as
Drosomycin and Immune induced molecule 1 (IM1) (18, 54).
The cytoplasmic components of the Toll signaling pathway
include MyD88, Pelle, Cactus, DIF, and Dorsal (17, 32, 39, 46,
50). These components are homologous to mammalian
MyD88, IRAK, IB, and NF-B, which are used in Toll-like
receptor, interleukin-1 receptor, and tumor necrosis factor re-
ceptor signaling (14). Therefore, evolutionarily conserved
pathways are employed in Drosophila and mammals to regulate
innate immunity.
The signaling molecules of the Toll and IMD pathways are
clearly distinct. Some antimicrobial peptide genes preferen-
tially respond to one of the two pathways. Therefore, it has
been generally accepted that the two pathways serve indepen-
dent functions and provide specificity in Drosophila innate im-
munity (3, 19, 38, 49). Meanwhile, a number of reports dem-
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onstrate that double mutants of the two pathways have
increased susceptibility to microbial challenge and that some
antimicrobial peptide genes are regulated, albeit to different
extents, by both pathways (7, 15, 16, 24, 40). Antimicrobial
peptide genes can be grouped based on the complex response
to the two signaling pathways. Induction of Diptericin and
Drosocin is highly defective in IMD pathway mutants; induc-
tion of Drosomycin and IM1 is highly defective in Toll pathway
mutants; induction of AttacinA, CecropinA, and Defensin is
defective to different degrees in either Toll or IMD pathway
mutants; and induction of Metchnikowin is not affected in ei-
ther Toll or IMD mutants but is defective in double mutants.
A mechanism that can explain these results is independent
activation of overlapping target genes by the two pathways. For
instance, some target promoters may contain binding sites for
both DIF and Relish: thus, they can be activated independently
by both pathways and the response depends on the affinity and
number of B sites. This mechanism fits nicely with all of the
available genetic and molecular analyses. Another mechanism
is cross-regulation of the two pathways, such as cross-modifi-
cation by a kinase, better formation of a common adaptor
complex, or cooperation of transcription factors. All of these
possible mechanisms do not need to be mutually exclusive and
can be employed at the same time in vivo. The mechanism of
pathway interaction so far has received little support from
experimental evidence. We show in this report that the two
pathways can synergistically activate the expression of antimi-
crobial peptide genes. When both pathways are simultaneously
stimulated at lower levels, the immunity genes are already
induced efficiently. We also demonstrate that the cooperation
is mediated through an interaction of the NF-B-related tran-
scription factors in the two pathways. This synergistic interac-
tion of two immune regulatory pathways illustrates how spe-
cific ligand binding by separate upstream pattern recognition
receptors can be translated into broad-spectrum host response,
a hallmark of innate immunity.
MATERIALS AND METHODS
Molecular cloning and dsRNA synthesis. Site-directed mutagenesis of B sites
on the Drosomycin promoter was performed in pBluescript Clone. The Strata-
gene QuickChange mutagenesis kit was used on a double-stranded DNA
(dsDNA) template. The first GGG residues in all of the B sites were changed
to ATT.
Constructs for dsRNA synthesis were made by inserting an EcoRI-PstI dorsal
cDNA fragment (nucleotides [nt] 555 to 1737 [ATG is 1]) and an XhoI-PstI
Relish cDNA fragment (nt 591 to 2334) into the pCCM113 vector, which contains
T7 promoter sequence on both ends. Three different Dif cDNA fragments (nt
135 to 725, 720 to 1580, and 1575 to 1990) were used for this series of experi-
ments. The experiments shown in Fig. 5 used the Dif fragment (nt 720 to 1580).
The pCCM113 clones were used as templates for PCR using Pfu DNA polymer-
ase (Stratagene) and T7 primer. The PCR products were purified from agarose
gel with QIAEX II (QIAGEN) and used as templates for in vitro transcription,
using the MEGAscript transcription kit (Ambion) and T7 polymerase. The
transcription products were denatured at 95°C for 5 min, renatured by gradual
cooling down to 24°C, and then purified with NucAway spin columns (Ambion).
Cell culture and RNA expression analyses. Drosophila Schneider-2 (S2) cells
were maintained at 25°C in Schneider’s Drosophila medium (Invitrogen) supple-
mented with 10% fetal bovine serum (HyClone), 100 U/ml penicillin, and 100
g/ml streptomycin (Invitrogen). For stimulation experiments, 2  106 cells were
cultured in six-well plates for 50 h and purified Spa¨tzleC106 protein (54) and
Escherichia coli O111:B4 peptidoglycan (InvivoGen) were added to the culture
cells. When ecdysone was included in the experiment, 20-hydroxyecdysone
(20-HE [Sigma]) was added at a concentration of 1 M 24 h before adding other
ligands. Cells were harvested 6 h or 20 h after stimulation. The RNA preparation
and Northern blot analysis were performed as described previously (13).
Quantitative reverse transcription-PCR (RT-PCR) was carried out with the
iScript cDNA synthesis kit (Bio-Rad) for cDNA synthesis and the iQ SYBR
green Supermix (Bio-Rad) and MyiQ single-color real-time PCR detection sys-
tem (Bio-Rad) for real-time PCR. The following gene-specific primers were
used: Drosomycin, 5-TACTTGTTCGCCCTCTTCG-3 and 5-GTATCTTCCG
GACAGGCAGT-3; Diptericin, 5-CCGCAGTACCCACTCAATCT-3 and 5-
ACTGCAAAGCCAAAACCATC-3; AttacinA, 5-AGGTTCCTTAACCTCCA
ATC-3 and 5-CATGACCAGCATTGTTGTAG-3; and Ribosomal protein 49,
5-AAGCTAGCCCAACCTGCTTC-3 and 5-GTGCGCTTCTTCACGA
TCT-3.
Transfection assay. Transient transfection was performed as described in the
protocol for the Lipofectin reagent (Invitrogen). Approximately 2  106 cells in
each well of six-well plates were transfected with 0.5 g of the Actin5C-Gal4
plasmid, 0.05 g of pUAST plasmids (Toll, PGRP-LC, and IMD), 0.5 g of
luciferase reporter plasmids, and 1 g of copia-lacZ plasmids. The AttacinA,
AttacinD, CecropinA1, Defensin, and Drosomycin promoter-luciferase reporters
contained 1.0 kb, 2.0 kb, 0.8 kb, 2.7 kb, and 2.9 kb of upstream sequences,
respectively. The Drosomycin promoter deletion mutants contained various
amounts of promoter sequence as indicated in Fig. 6A, and the B site mutants
were constructed within the 0.43-kb promoter. The transfected cells were grown
for 70 h and then harvested. For stimulation, the transfected cells were treated
with E. coli or peptidoglycans for 24 h before harvest. The bacteria used were E.
coli O55:B5, the cells of which were cultured overnight in 2 YT broth (QBIO-
gene), heat treated at 65°C for 15 min, and then added to S2 cells at a 1/100 final
dilution. Gram-negative peptidoglycan [PGN()] was from E. coli O111:B4
(Invivogen), and gram-positive peptidoglycan [PGN()] was from Staphylococ-
cus aureus (Fluka), with a final concentration of 10 g/ml. The harvested cells
were lysed in 0.1 M potassium phosphate buffer (pH 7.0) by repeated freeze-
thaw. Luciferase and -galactosidase activities were measured using D()-lucif-
erin (Roche) and o-nitrophenyl--D-galactopyranoside (Sigma) as substrates,
respectively.
For RNA interference (RNAi) experiments, 3 g of synthesized and column-
purified dsRNA was added with the plasmids and the Lipofectin reagent for
transient transfection.
Transgenic flies and natural infection. Male transgenic flies carrying the
gain-of-function mutant construct TollD (Toll755/781Y) on the 2nd chromosome
and PGRP-LC on the 3rd chromosome under the regulation by UAS promoter
were crossed with female flies carrying Yp1-, nanos-, Hsp70-, arm-, 132-, 127-,
362-, Actin5C-, rhomboid-, e33C-, or daughterless-Gal4 transgenes. Adult flies
were counted with the help of balancer marker chromosomes, and viability was
designated based on the number of expected flies obtained. For the crosses that
produced viable offspring, RNA was extracted from adult females of the next
generation containing both Gal4 and UAS transgenes. The RNA was subjected
to Northern blot analysis.
For natural infection, Canton-S females of age 2 to 4 days after eclosion were
dipped into a solution containing 1  106 spores/ml of Beauveria bassiana
(ATCC 9453), and then starved at 29°C for 2 h in empty vials. The flies were then
transferred into new vials which contain 2 cm by 3 cm of 3MM chromatography
paper (Whatman) soaked with 500 l of 5% sucrose–Pseudomonas entomophila
culture. The Pseudomonas entomophila culture used in these experiments was in
the logarithmic growth phase and was concentrated by centrifugation and added
to the sucrose solution to make the final concentration of 1 at an optical density
of 600 nm. Flies were fed with this sucrose-bacterium mixture at 29°C for 24 h
and then collected for RNA preparation.
RESULTS
Spa¨tzle and gram-negative peptidoglycan stimulate antimi-
crobial peptide genes cooperatively. Even though the Toll and
IMD pathways have separate components and preferential tar-
get genes, some target genes seem to be regulated by both
pathways (7, 16). Thus, we hypothesized that these two path-
ways could interact at some levels. We used Drosophila S2 cells
to test our hypothesis because S2 cells respond to immune
stimulants and allow more precise manipulation. The method
of injecting microbes into whole flies may stimulate more than
one pattern recognition receptor, and injury itself can cause
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some level of gene induction or prime the innate immune
response (1, 26, 31, 36).
In our experiments, a truncated Spa¨tzle protein that is con-
stitutively active was used to stimulate the Toll pathway and
PGN() was used to stimulate the IMD pathway (26, 54).
Spa¨tzle and PGN() are ligands of the receptors Toll and
PGRP-LC, respectively. The expression of endogenous anti-
microbial peptide genes was used to monitor the stimulations
(Fig. 1A). The Drosomycin gene is a widely used readout for
the Toll pathway, and the Diptericin, AttacinA, and CecropinA
genes are common readouts for the IMD pathway. The results
showed that direct stimulation for 20 h by the two ligands at
the same time induced the highest expression levels of four
different antimicrobial peptide genes (Fig. 1A, lane 4). In com-
parison, adding Spa¨tzle alone did not show detectable induc-
tion of these genes, while adding PGN() alone induced only
low-level expression of AttacinA and CecropinA (Fig. 1A, lanes
1 to 3).
Previous experiments show that S2 cells are more responsive
to stimulation after treatment with ecdysone, the master reg-
ulatory hormone of metamorphosis (8). After ecdysone (20-
HE) treatment, the cells became responsive to Spa¨tzle by ex-
FIG. 1. Synergistic induction of antimicrobial peptide genes by Spa¨tzle and peptidoglycan. (A) Total RNA was isolated from S2 cells treated
with different combinations of 1 M 20-hydroxyecdysone (20-HE), 2.4 nM Spa¨tzleC106 (SPZ), and 10 mg/ml peptidoglycan from Escherichia coli
[(PGN()] for 20 h as indicated. The RNA samples were analyzed by Northern blotting using the indicated gene probes for hybridization. The
autoradiographs are shown. (B) Dose-response study using various amounts of Spa¨tzleC106 and PGN() as indicated at the top of the panel. S2
cells were treated with the ligands, and RNA was isolated and analyzed by Northern blotting. The autoradiographs are shown. The results show
that all of the antimicrobial peptide genes tested can be activated synergistically by the two ligands in the S2 cells. (C) Total RNA was isolated
from S2 cells 6 h after stimulation. The RNA samples were analyzed by RT-PCR. The results are the average of three independent experiments,
and standard deviations are shown as error bars.
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pressing detectable level of Drosomycin (lane 6) and to
PGN() by expressing higher levels of Diptericin, AttacinA,
and CecropinA (lane 7). These results recapitulated the spec-
ificity of the response to the two ligands in whole flies. More
importantly, under the same condition, stimulation of the cells
with the two ligands together induced even higher expression
of all four genes (lane 8). Therefore, the cooperation of the
two pathways also takes place when the cells are primed to
respond after ecdysone treatment.
We then analyzed the dose response of S2 cells to this
cooperative stimulation. In this series of experiments, no
ecdysone was included. Spa¨tzle was used up to 12 nM and
PGN() was used up to 10 g/ml; these ranges of concentra-
tion are similar to those used in previous reports (21, 26, 54).
The two representative target genes of the Toll and IMD
pathways, Drosomycin and Diptericin, were assayed (Fig. 1B).
As expected, PGN() alone stimulated S2 cells to express a
detectable level of Diptericin and, to a lesser extent, of Droso-
mycin (lanes 1 to 4). Meanwhile, Spa¨tzle alone stimulated
Drosomycin better than Diptericin (lanes 9 to 12). When dif-
ferent concentrations of Spa¨tzle and PGN() were added to-
gether to the S2 cells, we observed a synergistic activation of
both Drosomycin and Diptericin. At the highest concentrations
used, the two target genes were expressed approximately 10-
fold higher than the additive signal induced by the individual
ligands (compare lane 8 to lanes 4 and 5). Therefore, there is
cooperation between these two ligands at various concentra-
tions to stimulate the innate immune response.
Antimicrobial peptide genes are induced with very different
kinetics. Diptericin and Attacin mRNA reach peak levels in
about 6 h, while Drosomycin mRNA reaches its peak level in
about 24 h. The different kinetics may represent complex reg-
ulation, both positive and negative, by multiple pathways on
target promoters. We tested whether the synergy also occurs at
an earlier time. The same conditions were used as in Fig. 1A,
and RNA samples isolated from the S2 cells were assayed by
quantitative real-time PCR. As shown in Fig. 1C, synergistic
activation of Drosomycin and AttacinA was detected at 6 h
poststimulation. The expression of other genes was also as-
sayed, and a lower degree of synergy was observed (data not
shown).
Synergy is not mediated through direct stimulation of Toll
by bacterial compounds. A logical explanation of the results
presented above is that Spa¨tzle and PGN() activate the Toll
and IMD pathways, respectively, and the two pathways coop-
erate to cause better activation of antimicrobial response.
However, it is also possible that PGN() acts on Toll directly
or that PGN() interacts with Spa¨tzle and the complex binds
to Toll. These situations will be similar to mammalian Toll-like
receptors, which can bind to microbial compounds or to mi-
crobial compound/host protein complexes (14). Therefore, we
examined further how the observed cooperation occurred.
Toll10b is a Toll point mutant, and the mutation renders the
receptor constitutively active in the absence of Spa¨tzle (18). In
these transfection experiments, we used an approximately 10-
fold-smaller amount (50 ng) of the plasmids compared to that
used (500 ng) in our previous report (34). This amount of
Toll10b plasmid caused a fivefold increase in reporter expres-
sion, while Toll plasmid had no effect. The addition of the
gram-negative bacterium E. coli further increased the re-
sponse, from 6- to 25-fold, of Toll10b-transfected cells (Fig.
2A). More importantly, the bacteria did not stimulate this
reporter in parental cells or Toll-transfected cells. These re-
sults are consistent with faster kinetics of gene induction in
FIG. 2. Constitutively active Toll synergizes with PGN() to stim-
ulate Drosomycin. S2 cells were transiently transfected with the ex-
pression vector for wild-type Toll, gain-of-function mutant Toll10b, or
gain-of-function deletion mutant TollN6, as indicated. All samples
were cotransfected with the Drosomycin-luciferase reporter gene. The
samples were then treated with gram-negative bacterium E. coli or with
2 YT growth medium as a control (A), and the luciferase activity in
the extract was assayed. All of the samples were normalized with
-galactosidase activity from the cotransfected lacZ plasmid. The lu-
ciferase activity of the S2 cells transfected with empty vector and
treated with PBS was set to 1; all other samples were plotted as relative
activity to this control. The results were the average of three indepen-
dent experiments, and the standard deviation is shown as error bars. In
panel B, similar transfection experiments were performed using pep-
tidoglycan from E. coli [PGN()] or S. aureus [PGN()], and the
luciferase activities were analyzed. In panel C, similar experiments
were performed, except the TollN6 construct was used. This con-
struct has the whole extracellular domain deleted and is constitutively
active as Toll10b. The results show that the constitutively active Toll
pathway, but not the extracellular domain, can synergize with PGN()
to stimulate Drosomycin.
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Toll10b mutant flies after septic injury (24). We further show
that similar synergistic interaction with Toll10b was observed
using PGN from gram-negative bacteria but not PGN from
gram-positive bacteria (Fig. 2B). These results together dem-
onstrate that PGN() synergistically stimulates the reporter
gene when the Toll pathway is already partially activated. How-
ever, the Toll10b protein still contains the whole extracellular
domain. Thus, we transfected another constitutively active Toll
construct, TollN6, which contains only the transmembrane
and intracellular domains (18). The TollN6-transfected cells
were also responsive to E. coli and PGN() stimulation (Fig.
2C). This result further supports the idea that PGN() exerts
the synergistic effect not by binding to the extracellular domain
of Toll but by activating another pathway.
Constitutive activation of both Toll and IMD pathways can
cause synergy. Previous reports have demonstrated that DAP-
type PGNs from gram-negative bacteria and some gram-posi-
tive bacteria such as bacilli stimulate the IMD pathway. These
DAP-type PGNs activate the IMD pathway by binding to
PGRP-LC and -LE (4, 6, 12, 21, 26, 29, 44, 47, 48). Therefore,
we speculated that the PGN() we used caused stimulation of
the IMD pathway receptor to synergize with the activated Toll.
Thus, we quantitatively analyzed the cooperative activation of
target genes in S2 cells by transfecting plasmids encoding
Toll10b and PGRP-LC. It has been demonstrated that overex-
pression of PGRP-LC or -LE is sufficient to activate the IMD
pathway constitutively (12, 48). Under our transfection condi-
tions, the Drosomycin-luciferase reporter was modestly acti-
vated by Toll10b or PGRP-LC. In contrast, the cotransfection
of both Toll10b and PRGP-LC highly activated this reporter
(Fig. 3A), demonstrating a synergistic effect of the two acti-
vated receptors. We similarly tested four other representative
promoters, the Defensin, CecropinA1, AttacinA, and AttacinD
gene promoters (Fig. 3B to E). The same amounts of Toll10b-
and PGRP-LC-encoding plasmids (50 ng each) were used
in the assay. Consistent with previous reports, CecropinA1,
AttacinA, and AttacinD exhibited strong responses to
PGRP-LC stimulation. The Defensin promoter had a relatively
weak response. Nonetheless, the presence of both Toll10b and
PGRP-LC always led to synergistic responses: that is, re-
sponses higher than the additive effect of the two receptors
when transfected alone. Although the levels of synergy differ
FIG. 3. Synergistic activation of antimicrobial peptide gene reporters by Toll10b and PGRP-LC. S2 cells were transiently transfected with the
expression vector for Toll10b and/or PGRP-LC, along with the luciferase reporter gene as indicated in each panel (A to E). Analysis of luciferase
activity, normalization of the results, and presentation of the graphs are the same as described in the legend to Fig. 2.
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among target genes, the results clearly indicate that Toll and
PGRP-LC synergistically activate the promoters of a battery of
antimicrobial peptide genes.
Synergistic interaction of Toll and IMD pathways in whole
flies. We used various means to examine whether the synergy
also occurs in whole animals. Septic injury experiments using
combinations of gram-positive (S. aureus and M. luteus) and
gram-negative (E. coli, Enterbacter cloacae, and Erwinia caro-
tovora) bacteria did not result in further increase of antimicro-
bial peptide gene expression (data not shown). We also in-
jected various amounts of gram-positive and gram-negative
peptidoglycans together, but again no further increase of gene
expression was observed. We surmised that the complexity of
whole bacteria used and the act of injury might have primed
the animals so that the response was already optimized and
thus no synergy could be detected.
To better control the activation of the two pathways, we
turned to the Gal4-UAS transgenic expression system. We
crossed Gal4 strains with UAS-TollD (a mutant similar to
Toll10b) (18) and UAS-PGRP-LC. A number of Gal4 lines we
tested affected viability of the flies. The offspring from Yp1-,
nanos-, Hsp70-, armadillo-, and 132-Gal4 crosses showed nor-
mal viability, while 127-, 362-, Actin5C-, and rhomboid-Gal4
caused lethality when both TollD and PRGP-LC were ex-
pressed (data not shown). Thus, we examined the expression of
antimicrobial peptide genes using the Gal4 crosses that pro-
duced viable adults. The Yp1-Gal4 driver has been widely used
to express transgenic constructs in adult female fat bodies (18,
50). The coexpression of TollD and PGRP-LC using this driver
did not result in synergy (Fig. 4A, right panel). We surmised
that the expression level driven by Yp1-Gal4 might be too high
so that each of the pathways was already activated optimally, as
supported by the robust expression of Drosomycin in TollD and
Diptericin in PGRP-LC lines. Meanwhile, there was a signifi-
cant increase in Drosomycin expression when both receptors
were expressed under the control of arm-Gal4. This driver is
supposed to cause a lower level of expression compared to
Yp1-Gal4. The Diptericin expression also showed a clear in-
crease, while modest synergy was observed for AttacinA and
Defensin (Fig. 4A, left panel). As controls, the use of arm-Gal4
crosses with either TollD or PGRP-LC led to no stimulation of
these antimicrobial target genes. Overall, the results are con-
sistent with the idea that when both pathways are stimulated at
lower levels, synergy can occur, but when stimulated at a higher
level each pathway can induce the target genes optimally and
independently.
We then tested whether synergy can occur when both path-
ways are stimulated during immune response in whole animals.
Previous reports show that natural infection by the fungus B.
bassiana activates antimicrobial peptide gene expression
through the Toll pathway (25). Meanwhile oral feeding of the
gram-negative bacterium P. entomophila causes activation of
antimicrobial response through the IMD pathway (53). We
first titrated down the amount of microbes so that there is
minimal expression of target genes after natural infection of
either microbe. Then we combined the two infection protocols
and after 24 h assayed for the expression of antimicrobial
peptide genes. We performed this experiment five times, and
the average result shows that there was detectable, albeit vari-
able, synergistic activation of Diptericin and CecropinA (Fig.
FIG. 4. Interaction of activated Toll and PGRP-LC in whole flies.
(A) The gain-of-function mutant TollD (see Materials and Methods) and
PGRP-LC were expressed in transgenic flies using the Gal4-UAS system.
The Gal4 drivers used are indicated. Expression ofDrosomycin,Diptericin,
AttacinA, and Defensin in the transgenic adult females expressing TollD
and PGRP-LC was examined. Northern blot analysis was carried out
using RNA from the female flies that resulted from armadillo- or Yp1-
Gal4 crosses with the indicated UAS lines. The autoradiographs are
shown. There is an increase in gene expression when both TollD and
PGRP-LC are expressed using the armadillo-Gal4 driver. (B) Double
natural infection of adult flies with fungi and gram-negative bacteria.
Adult female flies were soaked with fungal spores of Beauveria bassiana
(B.b) and then fed with entomopathogenic gram-negative bacterium
Pseudomonas entomophila (P.e) for 24 h. The gene expression was ana-
lyzed by quantitative RT-PCR. The results are the average of five inde-
pendent experiments, and standard deviations are shown as error bars.
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4B). Other antimicrobial peptide genes assayed showed only
marginal expression. The natural infection experiments are
difficult to control, and we used a smaller amount of microbes,
which thus may contribute to the highly variable results. Over-
all, the results suggest that at least under some circumstances
there is synergistic activation of antimicrobial peptide genes
through stimulation of Toll and IMD pathways during the
innate immune response.
Synergy depends on NF-B-related proteins. To investigate
the underlying mechanism that leads to the synergistic re-
sponse, we first performed a transfection assay using plasmids
encoding TollN6 and IMD. The expression of these two pro-
teins in S2 cells also synergistically activated the Drosomycin,
AttacinA, and CecropinA reporters (Fig. 5A to C). Because
TollN6 contains no extracelluar domain and IMD is a cyto-
plasmic adaptor, the synergy observed between the Toll and
IMD pathways should occur at an intracellular step.
Because of the varieties of intracellular signaling molecules
involved in the two pathways, various mechanisms can be en-
visaged, such as cross regulation by a kinase, better formation
FIG. 5. Requirement of NF-B-related proteins for synergistic activation. S2 cells were transiently transfected with different combinations of
the expression vector for TollN6 and IMD, along with the luciferase (luc) reporter gene of Drosomycin (A), CecropinA (B), or AttacinA (C).
Luciferase activity was analyzed and plotted as described in the legend to Fig. 2. (D) S2 cells were transiently transfected with the expression vector
for Toll10b and PGRP-LC, together with purified dsRNA. For dorsal and relish, 3 g of dsRNA was used. For Dif and snail, 3, 6, or 9 g of dsRNA
was used. The expression of the endogenous Drosomycin gene was analyzed by Northern blot hybridization after total RNA was extracted from
the S2 cells. The autoradiographs are shown. (E) S2 cells were transiently transfected with the expression vector for Toll10b and PGRP-LC, together
with 3 g of dsRNA for dorsal, Dif, relish, wntD, or the indicated combination. All samples also included the Drosomycin-luciferase reporter gene,
and luciferase activity was analyzed and plotted. The results together show that in the S2 cells, Dorsal and Relish are both required for the
synergistic activation of Drosomycin, while DIF does not play a role.
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of a common adaptor complex, or cooperation of transcription
factors. Our previous report using stably transfected S2 cells
showed that coexpression of DIF and Relish, as well as Dorsal
and Relish, activated Drosomycin more efficiently (13). Dorsal
and DIF act in the Toll pathway, and Relish acts in the IMD
pathway. If interaction of NF-B-related transcription factors
mediates the synergy, a prediction will be that the two recep-
tors stimulate the respective pathway independently down to
the transcription factors. Then the transcription factors in both
pathways will be critical for this response. If cross talk occurs
upstream of the transcription factors, then only one of the two
transcription factors will be involved. Thus, rather than testing
the many signaling components in the two pathways, we used
RNAi to directly knock down the expression of Dorsal, DIF,
and Relish and examined whether the activation of the target
gene was affected (Fig. 5D and E). We first showed that co-
transfection of Toll10b and PGRP-LC can efficiently activate
the expression of endogenous Drosomycin in the S2 cells (Fig.
5D, lanes 1 to 4). When the transfection experiment also in-
cluded dsRNA for dorsal or relish, we observed that each
caused almost total loss of expression of Drosomycin induced
by the two pathways (Fig. 5D, lanes 5 and 9). To our surprise,
we did not observe an involvement of DIF using the RNAi
approach; the amount of dsRNA used was sufficient to knock
down DIF expressed through transient transfection (data not
shown). DIF is the key transcription factor in the Toll-medi-
ated immune response in adult flies, while DIF and Dorsal
have redundant functions in larval immune response (32, 39).
In our S2 cells, the endogenous DIF may not be expressed
or functional: thus, Dorsal becomes the key factor in Toll
signaling.
Using the transiently transfected Drosomycin reporter as a
more quantitative assay, we observed similar results. Trans-
fected dorsal or relish dsRNA abolished the reporter activity
induced by the two pathways, but Dif RNAi had no effect (Fig.
5E). All of the results demonstrate that Dorsal and Relish,
downstream transcription factors of the Toll and IMD path-
ways, respectively, are critical for the synergistic activation in
the S2 cells. Thus, the interaction of the two pathways likely
occurs at the level of utilization of the NF-B-related proteins
in both pathways.
Synergistic activation through B sites on a target pro-
moter. To gain further insight into how the transcription fac-
tors regulate the response, we examined the Drosomycin pro-
moter in detail because it is a representative target and shows
a good response to activation by both pathways. The activity of
a series of deletion mutants (Fig. 6A and C) was analyzed by
transient transfection assay. The deletion of upstream se-
quences down to 0.43 kb increased the overall activity com-
pared to that of the parental 2.9-kb construct (Fig. 6C), sug-
gesting the presence of negative regulatory elements between
the 2.9- and 0.43-kb regions. Further deletion caused a steady
decline of promoter activity. The biggest drop of activity was
caused by deleting the region between the 0.43- and 0.14-kb
regions, demonstrating that the Toll and IMD pathway re-
sponse elements are mainly located within this 300-bp region
upstream of the transcription start site.
Within the 0.43-kb 5-flanking sequence, there are three
identifiable B sites (Fig. 6A). We made specific mutations of
each of these three B sites by changing the most conserved
5-GGG sequence to ATT (Fig. 6A and B) and analyzed them
in the context of the 0.43-kb promoter construct. Mutating the
three sites individually caused different effects, with site 1 and
site 2 having severe effects while site 3 had a minor effect (Fig.
6D). Moreover, mutating sites 1 and 2 together (mut12) or
simultaneously mutating all three sites (mut123) abolished the
activity. These results are consistent with the deletion analysis,
which reveals that the region between 0.43 and 0.14 kb, where
sites 1 and 2 are located, is responsible for most of the activity.
Thus, B sites 1 and 2 are critical elements that mediate the
Toll and IMD stimulation, while site 3 has only an auxiliary
role.
Careful analysis of the results reveals that the B sites 1 and
2 serve different functions. Mut1 showed a clear reduction of
the response to Toll10b stimulation, suggesting that DIF or
Dorsal binds to this site after stimulation of the Toll pathway.
The response to PGRP-LC, however, was not affected by mu-
tating site 1. Moreover, the synergistic response of mut1 was
still apparent, although the overall level was reduced. mut2, on
the other hand, showed no response to PGRP-LC stimulation,
while the response to Toll10b was partially reduced. Thus, site
2 is critical for the response to the IMD pathway and contrib-
utes to the response to the Toll pathway. Most importantly,
without site 2, the synergistic activation of the promoter by the
two pathways is much reduced. Thus, Relish likely binds to site
2 to mediate the IMD response. Overall the mutational anal-
ysis supports the idea that different NF-B-related proteins
bind to two B sites on the Drosomycin promoter and provide
the optimal condition for a synergistic response to the two
pathways.
DISCUSSION
In this study, we have shown that cooperation of the Toll and
IMD pathways can occur. One favorable condition is when
both pathways are activated at lower levels. This condition
perhaps resembles the invasion of microbes when flies suffer
injury in the natural environment. The cooperation of the
NF-B proteins will be particularly helpful when both signaling
pathways are stimulated by a low level of infection with mul-
tiple microbes, which is probably the most common scenario
when injury occurs in nature. A hallmark of innate immunity is
broad recognition and protection. Thus, our results reveal that
the innate immune system can combine two different pathogen
recognition signals to activate a wider spectrum of target genes
by cooperation of signaling pathways.
As shown in Fig. 7, we propose a model to illustrate how
Dorsal, DIF, and Relish interact with each other and the B
sites to mediate the synergistic response to Toll and PGRP-LC.
In our S2 cell experiments, Dorsal but not Dif is essential for
Drosomycin activation. In adult flies, DIF but not Dorsal is
critical (32, 39). In larvae, DIF and Dorsal have redundant
functions. Thus, we have presented DIF and Dorsal as having
equal functions in this model. Because the presence of both B
sites 1 and 2 gave the best overall response, binding of ho-
modimers or heterodimers of the transcription factors to these
two sites can account for the cooperative activation.
Site 1 matches the Dorsal binding consensus (GGGA/TA/T
T/AA/T/CCT/G/C), while site 2 matches the Relish binding
consensus (GGGAA/T/CNC/TC/AC/T) (41) (Fig. 6A). The
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FIG. 6. Synergistic activation of Drosomycin promoter involves two B sites. (A) Schematic representation of the promoter and the deletion
mutants analyzed for Drosomycin. The transcription start site is 1, and the end point of the upstream sequence is indicated. The three B sites
on the Drosomcyin promoter are as indicated, and the exact location and sequence are shown in the lower left corner. (B) Schematic representation
and nomenclature of the six B site point mutants of the 0.43-kb Drosomycin promoter-luciferase reporter. (C) Luciferase activity of the deletion
mutants of the Drosomycin promoter driven by Toll10b and PGRP-LC in transiently transfected S2 cells. The results shown are the average of three
independent experiments. (D) Luciferase activity of the B point mutants of the 0.43-kb Drosomycin promoter driven by Toll10b and PGRP-LC
in transiently transfected S2 cells. The results shown are the average of three independent experiments. The results indicate that B sites 1 and
2 are involved in the response to Toll and PGRP-LC stimulation.
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DIF binding selection showed ambiguous sequence except for
the first three G’s; thus, DIF may bind to a broad array of B
sites (41). It is likely that Dorsal or DIF homodimers can bind
to sites 1 and 2. Thus, mut1 and mut2 (Fig. 6D) both showed
a reduced response to Toll. Meanwhile, Relish can only bind to
site 2. Mutating site 2, therefore, abolished the response to
PGRP-LC. For cooperation to occur, the receptors may acti-
vate the respective homodimers, which then bind to sites 1 and
2 independently. DIF or Dorsal homodimers on site 1 then
cooperate with Relish homodimer on site 2 to activate the
transcription complex efficiently.
Alternatively, site 2 can bind Relish heterodimers (Dorsal/
Relish or DIF/Relish). DIF/Relish heterodimer has been
shown to have higher binding specificity in vitro (GGGAA/T
TCC/AC) (41), which is still similar to site 2. Using electro-
phoretic mobility shift assays, we previously showed that site 2
can bind Relish homodimer and heterodimers (13). Moreover,
DIF and Relish, as well as Dorsal and Relish, in stably trans-
fected S2 cells synergistically activate Drosomycin (13). In these
extracts, heterodimer formation was detected at a low level.
The binding of heterodimer to site 2 in vivo is further sup-
ported by the finding that mut2 had the most reduced synergy
(Fig. 6D) and that mut13 still has some synergistic response.
Therefore, it is possible that heterodimers of Relish on site 2
alone account for some response to both pathways and can
cooperate with Dorsal or DIF on site 1. Finally, we want to
emphasize that the utilizations of various dimers of the three
NF-B-related proteins can all happen in vivo and need not be
mutually exclusive.
IMD pathway mutants have preferential loss of induction of
genes including Diptericin. Toll pathway mutants on the other
hand have preferential loss of induction of Drosomycin. While
these genetic analyses clearly suggest that the two pathways
can function independently, the mutant animals represent ex-
treme cases such that one of the two pathways is totally inac-
tivated. For example, in dorsal Dif double mutants, the Relish
homodimer is the only combination that exists. In such a situ-
ation, the solo Relish binding site (site 2) on the Drosomycin
promoter may not be sufficient for the activation. The Dipteri-
cin and Attacin promoters may have a sufficient number of
binding sites for Relish so that the response to IMD pathway
remains sufficient. In a relish mutant, DIF or Dorsal ho-
modimers either cannot bind to the Diptericin promoter or
cannot activate without the help of Relish. In wild-type flies,
both pathways are working at the same time and all NF-B
dimer combinations are available. These dimer combinations
may all interact with the target promoters. Promoters of anti-
microbial peptide genes contain clusters of B sites (41). The
occupation of these B sites may determine the overall expres-
sion levels and the responsiveness to the Toll and IMD path-
ways.
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